Back to News
Market Impact: 0.4

Stocks making the biggest moves premarket: Jefferies, Oracle, Fifth Third, Micron and more

AXPCMACSXDBFITBHBANIBKRJEFKRELLYLUNRMETAMUNVOORCLOZKTFCWALZION
Corporate EarningsCompany FundamentalsBanking & LiquidityAnalyst InsightsTechnology & InnovationHealthcare & BiotechM&A & RestructuringTrade Policy & Supply Chain
Stocks making the biggest moves premarket: Jefferies, Oracle, Fifth Third, Micron and more

Premarket trading saw mixed performance among regional banks, with Zions, Fifth Third, Huntington, and Truist gaining on positive Q3 earnings or analyst upgrades, while Bank OZK declined on an earnings miss. Major movers included CSX and American Express rising on strong Q3 results and raised guidance, respectively. Conversely, pharmaceutical stocks Novo Nordisk and Eli Lilly each fell approximately 4% following former President Trump's comments on potential obesity drug cost reductions, and Micron Technology declined on reports of exiting the server chip business in China due to product bans.

Analysis

Regional bank stocks exhibited mixed performance, with Zions (+1%), Fifth Third (+2.8%), Huntington (+2%), and Truist (+2.8%) gaining on better-than-expected Q3 earnings or analyst upgrades, pushing the SPDR S&P Regional Banking ETF (KRE) up 0.4%. Conversely, Bank OZK (-2%) slipped after missing consensus earnings forecasts of $1.66 per share, reporting $1.59. This indicates a selective recovery within the subsector driven by individual financial health. Strong Q3 earnings reports drove gains in other sectors, with CSX (+2.5%) exceeding expectations at 44 cents EPS on $3.59 billion revenue, and American Express (+1%) beating forecasts with $4.14 EPS and $18.43 billion revenue while raising full-year guidance. Jefferies (+3%) rebounded on an Oppenheimer upgrade to outperform, citing limited exposure to First Brands. Intuitive Machines (+4.8%) also saw an upgrade to buy from Deutsche Bank, highlighting attractive risk-to-reward and commercial catalysts. However, policy and geopolitical risks impacted several stocks. Novo Nordisk and Eli Lilly both fell approximately 4% after former President Trump suggested lower obesity drug costs, introducing regulatory uncertainty. Micron Technology (-1.8%) declined on reports of exiting its China server chip business due to a 2023 product ban, underscoring ongoing trade tensions and supply chain challenges. Oracle (-2.4%) and Interactive Brokers (-2.6%) also saw declines despite positive news or earnings beats, suggesting broader market pressures.